Molecular Profiles’ Innovative Drug Development Services Win Queen’s Award for Enterprise 2011

Molecular Profiles, a leading pharmaceutical development service provider, today announced that it has been awarded a Queen's Award for Enterprise 2011 in the Innovation category for its nanoPASS (nanoscale Predictive Analytical Screening Solution) service platform.

Related Posts

Comments are closed.